Last reviewed · How we verify
Pharyngeal swab
At a glance
| Generic name | Pharyngeal swab |
|---|---|
| Sponsor | Assistance Publique Hopitaux De Marseille |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparing Expectorated and Induced Sputum and Pharyngeal Swabs for Cultures, AFB Smears, and Cytokines in Pulmonary Nontuberculous Mycobacterial Infection
- Identifying the Causes and Risk Factors of Pulmonary Exacerbations in Cystic Fibrosis
- Predicting Reactions and Effects of Drugs Immunotherapy and Complications Through Oncosafety (PREDICTO Clinical Study) (NA)
- Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin-Resistant Neisseria Gonorrhoeae
- Sepsis-3 Study in Northeast Thailand
- Singapore SARS-CoV-2 Human Challenge Study (NA)
- Asymptomatic Flu Project (NA)
- Radiological Characterization of Pulmonary Involvement in Patients With Hematological Diseases
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pharyngeal swab CI brief — competitive landscape report
- Pharyngeal swab updates RSS · CI watch RSS
- Assistance Publique Hopitaux De Marseille portfolio CI